To require the Secretary of Health and Human Services to conduct a study on the impacts of arsenic, cadmium, mercury, and lead in infant formula on infant health and establish standards for regulating the content of such substances in infant formula.
Summary
HR9949 is an early-stage bill requiring an HHS study on heavy metals in infant formula and potential standards. It authorizes no funding and has no direct market impact. No tickers meet the confidence gate for inclusion.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9949 is a study-only bill with no funding, no cosponsors, and no near-term market impact.
- 2.No publicly traded company is directly affected; the bill's potential regulatory impact is years away.
- 3.Investors should monitor committee activity for signs of momentum, but currently this is a low-priority signal.
Market Implications
No market implications at this stage. The bill does not affect any publicly traded company's revenue, costs, or competitive position. Infant formula manufacturers (e.g., $REED, private-label producers) are not publicly traded pure plays, and diversified food companies like $CAG or $CPB would face negligible impact from a study. No real market data is available for infant formula stocks.
Full Analysis
On July 27, 2026, Rep. Tom Barrett (R-MI-7) introduced HR9949, which directs the Secretary of Health and Human Services to study the health impacts of arsenic, cadmium, mercury, and lead in infant formula and to establish regulatory standards for these substances. The bill was referred to the House Committee on Energy and Commerce and has no cosponsors. It is in the earliest legislative stage with no funding authorized—this is a study mandate, not a procurement or spending bill. The money trail is absent: the bill does not appropriate or authorize any funds. No convergence exists with the provided presidential action on chemical manufacturing regulatory relief, which addresses a different policy domain (manufacturing compliance costs) with no connection to infant formula heavy metals. Structural winners and losers are not identifiable at this stage; the bill's impact depends on future regulatory rulemaking that would follow the study's completion, a process that typically takes years. Legislative steps remaining include committee hearings, markup, floor votes in both chambers, and potential presidential action—all uncertain given the early stage and single sponsor.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →